Low Back Pain

Lomber Disk Hernisinde Disk Restorasyon Hidrojel İmplant (Gelstixtm) Kullandığımız Hastalarda Sonuçlar: Retrospektif Kohort Çalışması

Introduction: The aim of this study is evaluting the results of disc restoration hidrogel implanted (GelstixTM) lomber disc hernia patients. Material-Method: Patients suffered from chronic back pain diagnosed lumber disc hernia who were admitted to Firat University Algology Clinic and treated with disc restoration hidrogel between January 2013 – January 2014 were evaluated. Cases were evaluated for demografic characteristics, magnetic resistance imaging findings, preoperative and postoperative VAS, complications, side effects and patients satisfaction after prosedure. Results: Of the operated 62 patients were 25 male (40,3%) and 37 female (59,7%). Mean age of all patients was 49,18±14,18 years, mean age of female patients was 50,81±13,37 years and mean age of male patients was 46,76±15,27 years. Mean duration of pain in female and male patients was 37,81±37,92 months and 25,36±33,58 months, respectively. Preoperative and postoperatif VAS scores of female and male patients were 8,24±1,09 and 7,88±1,01 and 3,56±2,11 and 3,76±2,17, respectively. Of the 62 patients suffered from 16 right leg pain (25,8%), 20 left leg pain (32,3%), 26 bilateral lower limb pain (41,9%). Of 62 patients 31 had no additional disorders (50%), 12 had cardiac disorders (19,4%), 3 had (4,8%) respiratory disorders, 7 had endocrine disorders (11,3%), 4 had both endocrine and cardiac disorders (6,5%), 2 had both cardiac and respiratory disorders (3,2%), 1 had both endocrine and respiratory disorders (1,6%), and 2 had both endocrine, cardiac and respiratory disorders (3,2%). Of the 62 patients 25 had bulging (40,3%), 5 had protrusion (8,1%), 4 had narrowed neural foramen (6,5%), 18 had bulging +narrowed neural foramen (29%), 3 had narrowed neural foramen + protrusion (4,8%) and 7 had bulging + protrusion (11,3%). Thirteen patients hadn’t had previous therapy (20,97%), transforaminal steroid injection was applied to 29 patients (46,77%) and medical threapy (such as NSAID, miyorelactants) was applied to 20 (32,26%). Levels of complaints were 2 at L2-L3 (3,2%), 17 at L3-L4 (27,4%), 28 at L4-L5 (45,2%) and 15 at L5-S1 (24,2%). Without L2-L3 level other operated levels had significant difference between preropeative VAS scores and postoperative VAS scores. The number of unsatissfied patients was 9 (14,5%), moderated satisfied patients number 16(25,8%),good satisfied patients number was 16 (25,8%), and perfectly satisfied patients number was 21 (33,9%). Conclusion: Disc restoration hidrogel is a safe minimal invasive technique with satisfactory results, low complication rates and low side effect risk especially in young and middle aged patients.

[Risk factors of unsatisfactory outcomes after percutaneous laser decompression of lumbar intervertebral discs]

OBJECTIVE

To study the risk factors of unsatisfactory clinical results after percutaneous laser decompression of the lumbar intervertebral disc (PLDD).

MATERIAL AND METHODS

A retrospective observational single-center study included medical records of patients who underwent lumbar PLDD for degenerative spine disease. We analyzed clinical and instrumental parameters potentially affecting the results of lumbar PLDD.

RESULTS

Clinical study included 82 patients who underwent PLDD for lumbar intervertebral disc degenerative disease. Mean postoperative follow-up period was 30.8±13.3 months. In 22 (26%) patients, unsatisfactory clinical outcomes were observed. According to binary logistic regression model, comorbidities (p=0.03), duration of disease over 12 months (p=0.03), low preoperative quality of life according to ODI score (more than 50%) (p=0.04), high body mass index (over 25 kg/m²) (p=0.02), severe intervertebral disc (p=0.04) and facet joint degeneration (p=0.01) and intervertebral disc height decrease more than 50% (p=0.01) were significantly associated with unsatisfactory clinical outcomes after lumbar PLDD for degenerative spine disease.

CONCLUSION

Identification of these risk factors of unsatisfactory clinical outcomes is important stage of preoperative preparation in patients scheduled for lumbar PLDD.

The effects of core stability training in nurses with nonspecific low back pain

To investigate the effect of core stability training on nonspecific low back pain (NSLBP) in nurses.The data were collected retrospectively by reviewing the patient's medical records and pain questionnaires in our rehabilitation center. A total of 40 nurses with NSLBP were included and divided into observation group and control group. Each group were given routine health education for NSLBP. Core stability training was performed in observation group for 4 weeks. Surface electromyography (sEMG) evaluation of erector spine and multifidus muscle, pain Numeric Rating Scale (NRS) and Japanese Orthopaedic Association (JOA) scores were evaluated and analyzed before and 4 weeks after intervention.There was no significant difference of NRS score and JOA score between two groups before intervention (P > .05, respectively). The NRS and JOA scores were significantly improved in both two groups after 4 weeks of intervention (P < .05, respectively). Moreover, the improvement of NRS and JOA scores in the observation group were better than those of the control group (P < .05, respectively). No significant difference of average electromyography (AEMG) or median frequency (MF) were noted between the healthy side and the affected side in both groups before or after intervention (P > .05, respectively). After 4 weeks of intervention, the AEMG of the healthy and the affected side of the two groups showed an improved trend without significant difference (P > .05, respectively). The MF of affected side was significantly higher 4 weeks after intervention than those before treatment in the observation and control group (P < .05, respectively).Core stability training can alleviate pain, improve the fatigue resistance of the core muscles and the balance of the functions of bilateral multifidus muscles in nurses with NSLBP.

[The assessment of efficacy and tolerability of the complex therapy of low back pain]

OBJECTIVE

To assess the efficacy of the complex therapy of nonspecific low back pain (LBP) with amelotex, calmirex, kompligamB in comparison with the monotherapy with amelotex.

MATERIAL AND METHODS

This observational study included sixty patients, aged 53.73±11.84 53 years, with nonspecific LBP. Patients were divided into 2 groups: the basic group (n=30) received calmirex (150mg 2 times a day during 10 days), amelotex (7.5 mg 2 times a day, 7 days) and kompligamB (1 ml once a day, 10 days). The control group (n=30) received only amelotex (7.5 mg 2 times a day, 7 days). The dynamics of the condition was assessed on a 10-point numerical rating scale (at rest, walking, palpation), the Oswestry functional status questionnaire (Oswestry Disability Index; ODI), as well as indicators of laboratory markers reflecting the severity of the inflammatory process (erythrocyte sedimentation rate, C-reactive protein (CRP)).

RESULTS

The severity of pain syndrome significantly decreased in both groups, to a greater extent in the basic group, and ODI indicators also significantly improved in the basic group. CRP indicators showed more pronounced changes in the basic group.

CONCLUSION

The complex therapy that affects all links in the formation of pain syndrome should be recommended to patients with LBP.

[Back pain and intervertebral disc degeneration in the International Classification of Diseases 11th revision]

In 2018, the World Health Organization introduced a new version of the International Classification of Diseases (ICD-11), which is preliminary and introductory in nature and will come into force on 1 January 2022. One of the most changed sections compared to ICD-10 is the section characterizing the spine pain syndrome and other manifestations of discogenic pathology. The article describes the terms and codes for the degenerative lesion of the intervertebral disk (IVD) in accordance with the requirements of ICD-11, which also agree with the definitions of the 2nd revision of the nomenclature and classification of the pathology of the lumbar IVD from 2014. The basic concepts of IVD degenerative changes are also revealed. The need to create a new revision of the domestic clinical classification of vertebrogenic neurologic pathology adapted to ICD-11 codes is underlined.

Chronic nonspecific (musculoskeletal) low back pain. Guidelines of the Russian Society for the Study of Pain (RSSP)

Examination of a patient with chronic low back pain (LBP) is aimed at eliminating its specific cause and assessing the social and psychological factors of chronic pain. The diagnosis of chronic nonspecific (musculoskeletal) LBP is based on the exclusion of a specific cause of pain, discogenic radiculopathy, and lumbar stenosis. It is advisable to identify possible pain sources: pathology of intervertebral disc pathology, facet joints, and sacroiliac joint and myofascial syndrome.

An integrated multidisciplinary approach (a high level of evidence), including therapeutic exercises, physical activity optimization, psychological treatments (cognitive behavioral therapy), an educational program (back pain school for patients), and manual therapy, is effective in treating chronic musculoskeletal LBP. For pain relief, one may use nonsteroidal anti-inflammatory drugs in minimally effective doses and in a short cycle, muscle relaxants, and a capsaicin patch, and, if there is depressive disorder, antidepressants (a medium level of evidence). Radiofrequency denervation or therapeutic blockages with anesthetics and glucocorticoids (damage to the facet joints, sacroiliac joint), back massage, and acupuncture (a low level of evidence) may be used in some patients.

Therapeutic exercises and an educational program (the prevention of excessive loads and prolonged static and uncomfortable postures and the use of correct methods for lifting weights, etc.) are recommended for preventive purposes.